Impact of Reimbursement for Biomarker Testing on Clinical Practice

Geoffrey R. Oxnard, MD; Lauren L. Ritterhouse, MD, PhD

Video Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library

Drs. Geoffrey Oxnard and Lauren Ritterhouse deliberate on ways reimbursement issues are impacting clinical practice, particularly CMS’s “14-Day Rule.”

Related Videos

January 30, 2014

Communicating Value of Personalized Medicine to All Stakeholders in Healthcare

Listen as Dr Argawala articulates the value proposition of personalized medicine for all stakeholders in healthcare.

January 20, 2016

Pathways to a Cancer Stem Cell

Dr Wainberg expands upon what makes these types of cells unique.